Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 188

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Early T cell and binding antibody responses are associated with COVID-19 RNA vaccine efficacy onset

Open access
Kalimuddin, Shirin, Tham, Christine Y.L., Qui, Martin, de Alwis, Ruklanthi, Sim, Jean X.Y., Lim, Joey M.E., Tan, Hwee-Cheng, Syenina, Ayesa, Zhang, Summer L., Le Bert, Nina, Tan, Anthony T., Leong, Yan Shan, Yee, Jia Xin, Ong, Eugenia Z., Ooi, Eng Eong, Bertoletti, Antonio, Low, Jenny G.·2021·Med

Abstract

Background RNA vaccines against coronavirus disease 2019 (COVID-19) have demonstrated ∼95% efficacy in phase III clinical trials. Although complete vaccination consisted of 2 doses, the onset of protection for both licensed RNA vaccines was observed as early as 12 days after a single dose. The adaptive immune response that coincides with this onset of protection could represent the necessary elements of immunity against COVID-19. Methods Serological and T cell analysis was performed in a cohort of 20 healthcare workers after receiving the first dose of the Pfizer/BioNTech BNT162b2 vaccine. The primary endpoint was the adaptive immune responses detectable at days 7 and 10 after dosing. Findings Spike-specific T cells and binding antibodies were detectable 10 days after the first dose of the vaccine, in contrast to receptor-blocking and severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) neutralizing antibodies, which were mostly undetectable at this early time point. Conclusions Our findings suggest that early T cell and binding antibody responses, rather than either receptor-blocking or virus neutralizing activity, induced early protection against COVID-19. Funding The study was funded by a generous donation from The Hour Glass to support COVID-19 research.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.medj.2021.04.003

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 188

Metadata

Authors
Kalimuddin, S., Tham, C. Y. L., Qui, M., de Alwis, R., Sim, J. X. Y., Lim, J. M. E., Tan, H.-C., Syenina, A., Zhang, S. L., Le Bert, N., Tan, A. T., Leong, Y. S., Yee, J. X., Ong, E. Z., Ooi, E. E., Bertoletti, A., & Low, J. G.
Venue
Med
Publisher
Elsevier BV
Published
2021-06
Volume
2
Issue
6
Pages
682-688.e4
ISSN
2666-6340 (ISSN-L)
OpenAlex
W3156886555
Cited by
188
References
11
FWCI
12.88
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Early T cell and binding antibody responses are associated with COVID-19 RNA vaccine efficacy onset. https://app.cochat.ai/papers/10.1016/j.medj.2021.04.003
The paper
Kalimuddin, S., Tham, C. Y. L., Qui, M., de Alwis, R., Sim, J. X. Y., Lim, J. M. E., Tan, H.-C., Syenina, A., Zhang, S. L., Le Bert, N., Tan, A. T., Leong, Y. S., Yee, J. X., Ong, E. Z., Ooi, E. E., Bertoletti, A., & Low, J. G. (2021). Early T cell and binding antibody responses are associated with COVID-19 RNA vaccine efficacy onset. Med. https://doi.org/10.1016/j.medj.2021.04.003

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.